TIGIT and Miyoshi myopathy: Our analysis of immune checkpoint molecules during lenalidomide maintenance therapy most strikingly showed that T cells form MM patients post ASCT express high levels of TIGIT, which was significantly higher than its expression on T cells from healthy individuals (data not shown).